Baxter completes acquisition of Claris Injectables, expanding generic injectable medicines
Baxter announced the completion of the acquisition of Claris Injectables Limited, a global generic injectables pharmaceutical company. With this acquisition, Baxter gains access to the complete Claris Injectables product portfolio and pipeline as well as three manufacturing plants. July 27, 2017